Report cover image

Opioid Drugs Market

Publisher Coherent Market Insights
Published Sep 05, 2023
Length 203 Pages
SKU # CMI18238120

Description

Opioid Drugs Market, by Drug Type (Codeine, Fentanyl, Morphine, Hydrocodone, Oxycodone, and Others), by Application (Analgesia, Cough Suppression, and Diarrhea Suppression), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically, they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, and suppressing cough. One of the first opioid drugs, ‘morphine’, was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous systems, thus providing relief from pain. Opioids are administered in the form of oral pills, parenteral liquids, patches, or lozenges. There are different types of prescription opioids available, such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone, which are prescribed by physicians for mainly treating pain.

Market Dynamics

The key market players are focused on organic growth strategies such as product launches and approval, and this is expected to drive market growth for the forecast period. Moreover, the growing geriatric population globally is expected to increase the usage of opioids, as elderly people are at high risk of chronic diseases such as cardiovascular diseases, arthritis, and cancer due to the high comorbid conditions. Thus, the rising prevalence of old people is expected to drive market growth. In addition, the increasing prevalence of chronic diseases such as cancer, chronic pain due to arthritis, lower back pain, fibromyalgia, and postsurgical pain is also expected to increase the usage of opioids as pain relieving agents, which is expected to drive market growth for the forecast period. For instance, as per the factsheet published by the Center for Disease Control and Prevention (CDC) in October 2021, about 1 in 4 U.S. adults (23.7%), or about 58.5 million people, have doctor-diagnosed arthritis, and this is expected to reach 78 million by 2045.

Key features of the study:
  • This report provides an in-depth analysis of the global opioid drugs market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global opioid drugs market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global opioid drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global opioid drugs market.
Opioid Drugs Market Detailed Segmentation:
  • By Drug Class:
  • Alkaloids
Morphine

Codeine
  • Semisynthetic Opioids
Oxycodone

Hydrocodone

Hydromorphone
  • Synthetic Opioids
Fentanyl

Alfentanil
  • By Application:
  • Analgesia
  • Cough Suppression
  • Diarrhea Suppression
  • By Route of Administration:
  • Oral
  • Topical
  • Parenteral
  • Others (Intramuscular, etc.)
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson
  • Endo International plc
  • Lupin Limited
  • Cadila Healthcare Limited
  • Purdue Pharma L.P.
  • AbbVie Inc.
  • Fresenius Kabi
  • Mallinckrodt Pharmaceuticals
  • Pfizer Inc.
  • Rhodes Pharmaceuticals L.P.
  • Sun Pharmaceutical Industries Limited
  • Nesher Pharmaceuticals (USA) LLC
  • Amneal Pharmaceuticals LLC
  • Trevena Inc.
  • Aurobindo Pharma Limited

Table of Contents

203 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Application
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
Reimbursement Scenario
PEST Analysis
PORTER’S Analysis
4. Global Opioid Drugs Market-COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Opioid Drugs Market, By Drug Class, 2018- 2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
Alkaloids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Segment Trends
Morphine
codeine
Semisynthetic Opioids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Segment Trends
Oxycodone
Hydrocodone
Hydromorphone
Synthetic Opioids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Segment Trends
Fentanyl
Alfentanil
6. Global Opioid Drugs Market, By Application, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
Analgesia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Segment Trends
Cough Suppression
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Segment Trends
Diarrhea Suppression
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Segment Trends
7. Global Opioid Drugs Market, By Route of Administration, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Segment Trends
Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Segment Trends
Parenteral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Segment Trends
Others (Intramuscular, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Segment Trends
8. Global Opioid Drugs Market, By Distribution Channel, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
9. Global Opioid Drugs Market, By Region, 2018-2030, (US$ Bn)
Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019-2030
Segment Trends
North America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa
10. Competitive Landscape
Company Profiles
Teva Pharmaceutical Industries Ltd.*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Johnson & Johnson
Endo International plc
Lupin Limited
Cadila Healthcare Limited
Purdue Pharma L.P.
AbbVie Inc.
Fresenius Kabi
Mallinckrodt Pharmaceuticals
Pfizer Inc.
Rhodes Pharmaceuticals L.P.
Sun Pharmaceutical Industries Limited
Nesher Pharmaceuticals (USA) LLC
Amneal Pharmaceuticals LLC
Trevena Inc.
Aurobindo Pharma Limited
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 45 market data tables and 35 figures on “Global Opioid Drugs Market”-Global forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us